Join
Live feed
·
INSIDERFilingvia Quantisnow
Exelixis Inc. logo

EVP, Research and Development Aftab Dana sold $2,056,278 worth of shares (48,383 units at $42.50), decreasing direct ownership by 7% to 664,778 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EXEL· Exelixis Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXEL (Exelixis Inc.) and more on Quantisnow.